GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as the immune system specialist channels its resources into recently approved rare disease drug mavorixafor.

The Drug Regulatory Authority of Pakistan (DRAP) has directed a nationwide crackdown on illegal importation, unlicensed manufacturing, and unethical ...

ETOWAH COUNTY, Ala. ( WBRC) - Etowah County Commissioner Shane Ellison has approved more than $50,000 to continue their fight against drugs in their county. Ellison says transferring over $53,000 in ...

Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...